Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by Trust Co. of Vermont

Trust Co. of Vermont grew its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 18.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,022 shares of the company’s stock after acquiring an additional 1,721 shares during the period. Trust Co. of Vermont’s holdings in Prestige Consumer Healthcare were worth $759,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. GAMMA Investing LLC lifted its position in shares of Prestige Consumer Healthcare by 51.3% during the second quarter. GAMMA Investing LLC now owns 776 shares of the company’s stock worth $53,000 after purchasing an additional 263 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after buying an additional 208 shares during the last quarter. Atria Investments Inc acquired a new position in shares of Prestige Consumer Healthcare in the 1st quarter worth approximately $1,246,000. Tidal Investments LLC grew its position in shares of Prestige Consumer Healthcare by 4.7% in the 1st quarter. Tidal Investments LLC now owns 5,748 shares of the company’s stock worth $417,000 after acquiring an additional 256 shares in the last quarter. Finally, Bayesian Capital Management LP bought a new stake in shares of Prestige Consumer Healthcare in the 1st quarter valued at approximately $213,000. Institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

PBH stock traded up $0.55 during mid-day trading on Tuesday, reaching $68.13. The company had a trading volume of 337,470 shares, compared to its average volume of 249,483. Prestige Consumer Healthcare Inc. has a one year low of $56.34 and a one year high of $75.31. The stock has a market capitalization of $3.38 billion, a P/E ratio of 16.34, a P/E/G ratio of 2.00 and a beta of 0.49. The company has a quick ratio of 2.02, a current ratio of 3.20 and a debt-to-equity ratio of 0.68. The stock’s 50-day simple moving average is $67.88 and its two-hundred day simple moving average is $68.43.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Tuesday, May 14th. The company reported $1.02 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.12). Prestige Consumer Healthcare had a net margin of 18.60% and a return on equity of 13.48%. The firm had revenue of $277.00 million during the quarter, compared to the consensus estimate of $287.42 million. During the same quarter in the prior year, the business earned $1.07 earnings per share. The company’s revenue for the quarter was down 3.1% compared to the same quarter last year. Research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have commented on PBH. DA Davidson raised shares of Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $65.00 to $93.00 in a report on Friday, June 21st. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $80.00 price target on shares of Prestige Consumer Healthcare in a report on Tuesday, May 21st. Finally, StockNews.com downgraded shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $98.25.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.